India, U.S. to collaborate on COVID-19 vaccine trials, say U.S. health officials

sfg-2026
ForumIAS LATEST
    1. 15 Sept. | Current Affairs Pre-cum-Mains 2027 Morning 11 AM batch starts from 15th Sept. Click Here to Read More →
    2. 14 Sept. | Forum Residential Coaching (FRC) for UPSC preparation Click Here to know more →
    3. 14 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 14th Sept. Click Here to Read More →

News:India and the U.S have decided to work together on vaccine research and testing for COVID-19 under the Indo-U.S. Vaccine Action Program(VAP).

Facts:

  • The Indo-US Vaccine Action Programme(VAP) is a bilateral programme established in 1987.
  • Aim: To develop and evolve joint R&D projects towards development of safe and efficacious vaccines against some of the major communicable diseases that presently take a large toll in India & USA.
  • Nodal Agencies: U.S. National Institutes of Health, Indian Department of Biotechnology(DBT) and Indian Council of Medical Research(ICMR) along with other partners.

Additional Facts:

Global Vaccine Action Plan(GVAP):

  • It is a framework adopted at the 65th World Health Assembly in 2012 to achieve the vision of the Decade of Vaccines 2011-2020(DoV).
  • Aim: To prevent millions of deaths by 2020 through more equitable access to existing vaccines for people in all communities.
Print Friendly and PDF
Blog
Academy
Community